NAS:LSB (China)
Â
Ordinary Shares
$
2.0867
-0.24 (-10.48%)
11:08 PM EST
Warning! GuruFocus detected
5 Severe warning signs
with LSB.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
LakeShore Biopharma Co Ltd
NAICS : 541714
SIC : 2834
ISIN : KYG9845F1090
Share Class Description:
LSB: Ordinary SharesDescription
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | -2.32 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -2.1 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.2 | |||||
| 3-Year EBITDA Growth Rate | -35 | |||||
| 3-Year EPS without NRI Growth Rate | -5.3 | |||||
| 3-Year FCF Growth Rate | 9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.45 | |||||
| 9-Day RSI | 36.51 | |||||
| 14-Day RSI | 41.71 | |||||
| 3-1 Month Momentum % | -44.89 | |||||
| 6-1 Month Momentum % | -62.57 | |||||
| 12-1 Month Momentum % | -77.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.17 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 1436.12 | |||||
| Days Sales Outstanding | 627.4 | |||||
| Days Payable | 465.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.3 | |||||
| Shareholder Yield % | 45.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.89 | |||||
| Operating Margin % | -61.47 | |||||
| Net Margin % | -63.61 | |||||
| FCF Margin % | -124.44 | |||||
| ROE % | -29.78 | |||||
| ROA % | -11.41 | |||||
| ROIC % | -17.37 | |||||
| 3-Year ROIIC % | -20.63 | |||||
| ROC (Joel Greenblatt) % | -21.58 | |||||
| ROCE % | -20.5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 15.01 | |||||
| PS Ratio | 0.5 | |||||
| PB Ratio | 0.47 | |||||
| Price-to-Tangible-Book | 0.53 | |||||
| EV-to-EBIT | -3.94 | |||||
| EV-to-EBITDA | -3.94 | |||||
| EV-to-Revenue | 2.33 | |||||
| EV-to-Forward-Revenue | 1.39 | |||||
| EV-to-FCF | -1.87 | |||||
| Price-to-Net-Current-Asset-Value | 13.04 | |||||
| Earnings Yield (Greenblatt) % | -25.38 | |||||
| FCF Yield % | -118.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LSB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LakeShore Biopharma Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 37.881 | ||
| EPS (TTM) ($) | -2.897 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 108.75 | ||
| 14-Day RSI | 41.71 | ||
| 14-Day ATR ($) | 0.237231 | ||
| 20-Day SMA ($) | 2.268425 | ||
| 12-1 Month Momentum % | -77.3 | ||
| 52-Week Range ($) | 1.8107 - 11.2 | ||
| Shares Outstanding (Mil) | 19.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LakeShore Biopharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LakeShore Biopharma Co Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
LakeShore Biopharma Co Ltd Frequently Asked Questions
What is LakeShore Biopharma Co Ltd(LSB)'s stock price today?
The current price of LSB is $2.09. The 52 week high of LSB is $11.20 and 52 week low is $1.81.
When is next earnings date of LakeShore Biopharma Co Ltd(LSB)?
The next earnings date of LakeShore Biopharma Co Ltd(LSB) is 2025-04-18 Est..
Does LakeShore Biopharma Co Ltd(LSB) pay dividends? If so, how much?
LakeShore Biopharma Co Ltd(LSB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers